stockportfolio.pro
Stocks / PGNY vs XRAY
PGNY vs XRAY
Progyny, Inc. and DENTSPLY SIRONA Inc. side by side — fundamentals from SEC filings, refreshed nightly. Sector: Healthcare.
| Progyny, Inc. (PGNY) | DENTSPLY SIRONA Inc. (XRAY) | |
|---|---|---|
| Market cap | $2.0B | $2.0B |
| Revenue (latest FY) | $1.29B | $3.68B |
| Net income (latest FY) | $58.52M | $-598.00M |
| Revenue growth (5y CAGR) | 30.2% | 2.0% |
| Net margin | 4.5% | -16.3% |
| Return on equity | 11.3% | -44.7% |
| P/E ratio | 33.5 | — |
| Dividend yield | — | 5.0% |
| Profitable years (of last 10) | 7 | 3 |
| Positive free cash flow | Yes | Yes |
Compare them properly — statement by statement
Open either company interactively: 19 years of income statement, balance sheet and cash flow, ratios, health checks, and Ask — the SEC-grounded research assistant.
Open PGNY — free Open XRAY — freeFrequently asked questions
Which is bigger, PGNY or XRAY?
DENTSPLY SIRONA Inc. is larger by market capitalization — $2.0B versus $2.0B.
Which grows faster, PGNY or XRAY?
Over the last five fiscal years, Progyny, Inc. grew revenue faster — 30.2%/yr versus 2.0%/yr, computed from SEC-filed statements.
Where does this data come from?
All figures are computed from official SEC filings (10-K), refreshed nightly. This is a data comparison, not investment advice.